Phio Pharmaceuticals Corp reports results for the quarter ended in September - Earnings Summary

Phio Pharmaceuticals

11/11/2022 24:14

* Phio Pharmaceuticals Corp  PHIO.OQ  reported a quarterly
adjusted loss of 26 cents​​ per share for the quarter ended in
September. The lone analyst forecast for the quarter was
for earnings of 36 cents per share.
    * Reported revenue was zero​; analysts expected $12.50
million. 
    * Phio Pharmaceuticals Corp's reported EPS for the quarter
was a
loss of 26 cents​.
    * The mean earnings estimate of analysts had risen by
about 271.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Phio Pharmaceuticals Corp shares had risen by 1.8% this
quarter and lost 41.9% so far this year.
    * The company reported a quarterly loss of $3.58 million.
    * Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
11 at 12:14 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.36           -0.26          Missed
 Jun. 30 2022      -0.31          -0.19          Beat
 Mar. 31 2022      -0.30          -0.19          Beat
 Dec. 31 2021      -0.32          -0.27          Beat